Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Academy for Sickle Cell and Thalassaemia (ASCAT 2026) 7 - 10 October 2026

Transfusion-dependent SCD: management challenges and emerging phase 2 evidence for etavopivat

Authors :

Beng Richard Fuh^1*, Mona Hamdy², Saranya Veluswamy³, Kevin H.M. Kuo^4,5, Sunil Navani⁶, Olga Polyanskaya⁷, Navid Nedjatian⁸, Ashutosh Lal⁹

Affiliations

View Details Hide Details

Keywords

Sickle Cell Disease

Congress oral presentation

Etavopivat